ClinicalTrials.gg
Not yet recruitingNCT06885398Updated Mar 20, 2025

Intra Arrest Ventilation in Human Cadavers II

An interventional study of treatment in Ventilation During Resuscitation, sponsored by Muehlenkreiskliniken, MKK. Not yet recruiting. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-03-20.

Sponsored by Muehlenkreiskliniken, MKK · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Apr 2025, 1 year 7 months ago, but the record still lists the study as not yet recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
3
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The study investigates the influence of three types of ventilation mode by using Bi-Level positive airway pressure (pinsp 20 mbar, PEEP 5, AF 10/min) with two different types of ventilators ( Medumat vs. MeduVENT ), Continuous positive airway pressure (PEEP 5, AF 10/min, ASB 10) and Chest Compression Synchronized Ventilation (pInsp = 30 vs. 60 mbar; respiratory rate = chest compression rate, PEEP 5) with regard to achieving a sufficient tidal volume and the tightness of various supraglottic airway devices (laryngeal mask, i-Gel-laryngeal mask, laryngeal tube) and endotracheal intubation.

Read the detailed description

The European Resuscitation Council (ERC) guidelines for cardiopulmonary resuscitation (CPR) recommend uninterrupted chest compressions and continuous ventilation as soon as a patient is endotracheally intubated or a supraglottic airway (SGA) is positioned.

Recently, SGAs have been adopted by emergency medical services worldwide as the primary tool for airway management during CPR. SGAs offer limited protection against aspiration compared to endotracheal intubation (ETI) and may increase the risk of aspiration. A new ventilation mode (Chest Compression Synchronized Ventilation [CCSV]) is now available for resuscitation with uninterrupted chest compressions.

The study investigates the influence of three types of ventilation mode by using Bi-Level positive airway pressure with two kind ventilators (pinsp 20 mbar, PEEP 5, AF 10/min), Continuous positive airway pressure (PEEP 5, AF 10/min, ASB 10) and Chest Compression Synchronized Ventilation (pInsp = 30 vs. 60 mbar; respiratory rate = chest compression rate, PEEP 5) with regard to achieving a sufficient tidal volume and the tightness of various supraglottic airway devices (laryngeal mask, i-Gel-laryngeal mask, laryngeal tube) and endotracheal intubation.

Gender, age, height and weight are documented (external post-mortem examination). The respective body donor is randomly assigned to a group. The grouping determines the order in which the means of airway management (SGA, ETI) are used.

Initial airway management is performed with an ETI with blockage of 40 mmH2O). The body donor is then bronchoscoped. A gastric tube is placed and the pressure probe to be used is calibrated if necessary. Positive pressure ventilation (pInsp = 35 mbar, positive end-expiratory pressure (PEEP) = 12 mbar, frequency = 10 min-1) is performed for 2 minutes to recruit the lungs. Vt is documented.

Mechanical cardiopulmonary resuscitation (CPR) is then performed for minutes (4 cycles) using the mechanical chest compression device in accordance with ERC 2015. Ventilation pressure and flow curves are continuously recorded by the respirator (Medumat Standard² and MeduVENT by the company Weinmann GmbH). Leaks are detected via the automatically initiated ventilation curves, measured and recorded by the ventilator. Ventilation takes place for 4 minutes with CPAP ASB, 4 minutes in BIPAP mode with Medumat, 4 minutes with MeduVENT and 4 minutes in CCSV mode with an pinsp of 30 and 4 minutes with 60 mbar . At the end of the cycle, the body donor is intubated with one of the remaining airway devices, and the lungs are recruited again and mechanical CPR is performed again for 20 minutes using the 3 ventilation modes. All in all the time durance of CPR for one donor will be 100 minutes by using all four airway devices.

02

Conditions studied

  • Ventilation During Resuscitation

Keywords

  • Cardiac arrest
  • Airway management
  • Cadaver
  • Heart diseases
  • Heart arrest
  • Death
  • cardiovascular diseases
03

In context

Heart Arrest

927 studies on the registry are indexed under Heart Arrest; 227 are open to participants now.

This study's planned enrollment of 3 is below the median of 100 across 519 interventional studies indexed under Heart Arrest.

Browse Heart Arrest studies →

Lead sponsor

Muehlenkreiskliniken, MKK is the lead sponsor of 2 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • more than 18 years of age

Exclusion criteria

Exclusion Criteria:

  • Adult respiratory distress syndrome (ARDS)
  • Severe lung or thoracic injuries
  • Pneumothorax
  • Abnormal airways
  • Tracheostoma
  • severe aspirations
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
3 participants (estimated)

Study arms

  • Active comparator
    BIPAP (Bi-Level positive airway pressure)

    Other: treatment

  • Active comparator
    CPAP ASB (continouos positive airway pressure with assisted spontaneous breathing)

    Other: treatment

  • Active comparator
    CCSV (Chest Compression Synchronized Ventilation)

    Other: treatment

Interventions

  • Othertreatment

    * Endotracheal Tube Ventilation with an endotracheal tub * Laryngeal tube Ventilation with a laryngeal tube * Laryngeal mask Ventilation with a laryngeal mask * I-Gel-Laryngeal Mask Ventilation with an I-Gel-laryngeal mask

06

What researchers measure

Primary outcomes

  1. gained tidalvolume with different airway devices in BIPAP

    mean expiratory volume compared to ideal tidalvolume gained by using different airway devices in BIPAP

    Time frame: After beginning of ventilation up to 4 minutes each device

  2. gained ventilation volume with different airway devices in CPAP-ASB

    mean ventilation volume compared to ideal ventilation volume gained by using different airway devices in CPAP-ASB

    Time frame: After beginning of ventilation up to 4 minutes each device

  3. occurred ventilation pressure with different airway devices in CCSV

    mean ventilation pressure needed to develope a sufficient tidalvolume by using different airway devices in CCSV

    Time frame: After beginning of ventilation up to 4 minutes each device

Secondary outcomes

  1. Mean peak pressure

    Mean peak pressure during ventilation

    Time frame: After beginning of ventilation up to 4 minutes each device

  2. Inspiratory pressure

    Inspiratory pressure during ventilation

    Time frame: After beginning of ventilation up to 4 minutes each device

  3. Peak pressure

    Peak pressure during ventilation

    Time frame: After beginning of ventilation up to 4 minutes each device

  4. Leakage volume

    Leakage volume during ventilation

    Time frame: After beginning of ventilation up to 4 minutes each device

  5. Respiratory Rate

    Respiratory Rate during ventilation

    Time frame: After beginning of ventilation up to 4 minutes each device

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Apr 2025; primary completion for Apr 2025, 0 months later.

Of 205 non-industry interventional studies with no phase under Heart Arrest, half reached primary completion within 29 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 47. This study's planned 0 months is below that.

Counting every sponsor, half of 219 studies reached it within 28 months; a quarter within 10 and three quarters within 48.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 26, 2025
First posted
Mar 20, 2025
StartEst.
Apr 1, 2025
Primary completionEst.
Apr 6, 2025
CompletionEst.
Dec 30, 2025
Last update
Mar 20, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 20, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06885398
Lead sponsor
Muehlenkreiskliniken, MKK
Responsible party
Sponsor
First posted
Mar 20, 2025
Start date
Apr 1, 2025 (estimated)
Primary completion
Apr 6, 2025 (estimated)
Completion
Dec 30, 2025 (estimated)
Last update
Mar 20, 2025

Study contacts

Gerrit Jansen
Contact
gerrit.jansen@muehlenkreiskliniken.de
004957179054401
Jochen Hinkelbein
Contact
Jochen.hinkelbein@muehlenkreiskliniken.de
004957179054401

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Feb 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion